Lusine Yaghjyan

Lusine Yaghjyan

Auto-generated profile, based on publicly available information

Lusine Yaghjyan

University of Florida, College of Public Health and Health Professions and College of Medicine, Department of Epidemiology, Gainesville, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

6 April 2017 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
LYLusine Yaghjyan
Lusine Yaghjyan
RARobert Arao
Robert Arao
CBCole Brokamp
Cole Brokamp
EOEllen S. O’mEara
Ellen S. O’mEara
BSBrian L. Sprague
Brian L. Sprague
PRPatrick Ryan
Patrick Ryan
Mammographic breast density is a well-established strong risk factor for breast cancer. The environmental contributors to geographic variation in breast density in urban and rural areas are poorly understood. We examined the association between breast density and exposure to ambient air pollutants (particulate matter <2.5 μm in diameter (PM2.5) and ozone (O3)) in a large population-based screening registry. Participants included women undergoing mammography screening at imaging facilities within the Breast Cancer Surveillance Consortium (2001–2009). We included women aged ≥40 years with known residential zip codes before the index mammogram (n = 279,967). Breast density was assessed using the American College of Radiology’s Breast Imaging-Reporting and Data System (BI-RADS) four-category breast density classification. PM2.5 and O3 estimates for grids across the USA (2001–2008) were obtained from the US Environmental Protection Agency Hierarchical Bayesian Model (HBM). For the majority of women (94%), these estimates were available for the year preceding the mammogram date. Association between exposure to air pollutants and density was estimated using polytomous logistic regression, adjusting for potential confounders. Women with extremely dense breasts had higher mean PM2.5 and lower O3 exposures than women with fatty breasts (8.97 vs. 8.66 ug/m3 and 33.70 vs. 35.82 parts per billion (ppb), respectively). In regression analysis, women with heterogeneously dense vs. scattered fibroglandular breasts were more likely to have higher exposure to PM2.5 (fourth vs. first quartile odds ratio (OR) = 1.19, 95% confidence interval (CI) 1.16 − 1.23). Women with extremely dense vs. scattered fibroglandular breasts were less likely to have higher levels of ozone exposure (fourth vs. first quartile OR = 0.80, 95% CI 0.73–0.87). Exposure to PM2.5 and O3 may in part explain geographical variation in mammographic density. Further studies are warranted to determine the causal nature of these associations.

28 June 2016 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
LYLusine Yaghjyan
Lusine Yaghjyan
GCGraham A. Colditz
Graham A. Colditz
BRBernard Rosner
Bernard Rosner
KBKimberly A Bertrand
Kimberly A Bertrand
RTRulla M. Tamimi
Rulla M. Tamimi

25 August 2020 in Cancer Causes & Control
Verified
Journal Article
Closed access
PDF file
EKEmily Klann
Emily Klann
JWJessica M. Williamson
Jessica M. Williamson
MTMassimiliano S Tagliamonte
Massimiliano S Tagliamonte
MUMaria Ukhanova
Maria Ukhanova
JAJaya Ruth Asirvatham
Jaya Ruth Asirvatham
VMVolker Mai
Volker Mai

1 October 2016 in Reproductive Toxicology
Verified
Journal Article
Closed access
LYLusine Yaghjyan
Lusine Yaghjyan
GGGabriela L. Ghita
Gabriela L. Ghita
MDMarilyn Dumont-Driscoll
Marilyn Dumont-Driscoll
RYRichard Yost
Richard Yost
SCSu-Hsin Chang
Su-Hsin Chang

14 December 2022 in Frontiers in Medicine
Verified
Journal Article
Open access
LYLusine Yaghjyan
Lusine Yaghjyan
YHYujing J. Heng
Yujing J. Heng
GBGabrielle M. Baker
Gabrielle M. Baker
VBVanessa Bret-Mounet
Vanessa Bret-Mounet
DMDivya Murthy
Divya Murthy
RTRulla M. Tamimi
Rulla M. Tamimi
Background: The data on the expression of stem cell markers CD44, CD24, and ALDH1A1 in the breast tissue of cancer-free women is very limited and no previous studies have explored the agreement between pathologist and computational assessments of these markers. We compared the immunohistochemical (IHC) expression assessment for CD44, CD24, and ALDH1A1 by an expert pathologist with the automated image analysis results and assessed the homogeneity of the markers across multiple cores pertaining to each woman.Methods: We included 81 cancer-free women (399 cores) with biopsy-confirmed benign breast disease in the Nurses’ Health Study (NHS) and NHSII cohorts. IHC was conducted with commercial antibodies [CD44 (Dako, Santa Clara, CA, USA) 1:25 dilution; CD24 (Invitrogen, Waltham, MA, USA) 1:200 dilution and ALDH1A1 (Abcam, Cambridge, United Kingdom) 1:300 dilution]. For each core, the percent positivity was quantified by the pathologist and Definiens Tissue Studio. Correlations between pathologist and computational scores were evaluated with Spearman correlation (for categorical positivity: 0, >0–10–50, and >50%) and sensitivity/specificity (for binary positivity defined with 1 and 10% cut-offs), using the pathologist scores as the gold standard. Expression homogeneity was examined with intra-class correlation (ICC). Analyses were stratified by core [normal terminal duct-lobular units (TDLUs), benign lesions] and tissue type (epithelium, stroma).Results: Spearman correlation between pathologist and Definiens ranged between 0.40–0.64 for stroma and 0.66–0.68 for epithelium in normal TDLUs cores and between 0.24–0.60 for stroma and 0.61–0.64 for epithelium in benign lesions. For stroma, sensitivity and specificity ranged between 0.92–0.95 and 0.24–0.60, respectively, with 1% cut-off and between 0.43–0.88 and 0.73–0.85, respectively, with 10% cut-off. For epithelium, 10% cut-off resulted in better estimates for both sensitivity and specificity. ICC between the cores was strongest for CD44 for both stroma and epithelium in normal TDLUs cores and benign lesions (range 0.74–0.80). ICC for CD24 and ALDH1A ranged between 0.42–0.63 and 0.44–0.55, respectively.Conclusion: Our findings show that computational assessments for CD44, CD24, and ALDH1A1 exhibit variable correlations with manual assessment. These findings support the use of computational platforms for IHC evaluation of stem cell markers in large-scale epidemiologic studies. Pilot studies maybe also needed to determine appropriate cut-offs for defining staining positivity.